z-logo
open-access-imgOpen Access
Transapical transcatheter aortic valve replacement with the balloon expandable aortic bioprosthetic valve in high risk patients with severe aortic stenosis: Intermediate-term results from the register of the clinic of cardiac surgery
Author(s) -
Michal Hulman,
Martin Borggrefe,
Panagiotis Artemiou,
Ivo Gašparovič,
Vladan Hudec,
J. Hasakova
Publication year - 2019
Publication title -
bratislavské lekárske listy/bratislava medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 32
eISSN - 1336-0345
pISSN - 0006-9248
DOI - 10.4149/bll_2019_074
Subject(s) - medicine , ejection fraction , stenosis , euroscore , ventricle , cardiology , balloon , surgery , cardiac surgery , valve replacement , aortic valve stenosis , aortic valve , aortic valvuloplasty , aortic valve replacement , heart failure
The purpose of this study is to report our experience in performing transapical (TA) TAVR with a balloon-expandable valve only by cardiac surgeons, with on site interventional cardiology support.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here